Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 13/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL535692 | 0.83 | KDM4E (0.40) | HSD11B1KDM4EL3MBTL1NPC1RAB9A | |
| SCHEMBL17023407 | 0.83 | EPHX2 (0.47) | EPHX2HSD11B1KDM4EL3MBTL1NPC1 | |
| SCHEMBL22421823 | 0.79 | MAPT (0.44) | KDM4EL3MBTL1NPC1RAB9AMAPT | |
| SCHEMBL8149940 | 0.78 | IDH1 (0.44) | NPC1RAB9AMAPT | |
| SCHEMBL30361915 | 0.77 | CAPN1 (0.46) | KDM4EL3MBTL1NPC1RAB9AMAPT | |
| SCHEMBL28324866 | 0.77 | EPHX2 (0.50) | EPHX2HSD11B1GAAMAPTMEN1 | |
| SCHEMBL6449976 | 0.76 | EPHX2 (0.41) | EPHX2HSD11B1KDM4EGAAMEN1 | |
| SCHEMBL28877061 | 0.75 | EPHX2 (0.49) | EPHX2HSD11B1GAAMAPT | |
| SCHEMBL2733207 | 0.74 | MAPT (0.33) | EPHX2HSD11B1KDM4EL3MBTL1NPC1 | |
| SCHEMBL21571872 | 0.74 | KDM4E (0.40) | KDM4EL3MBTL1NPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9173400-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| US-9113630-B2 | Method of controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-25 | — | — | US | disclosed |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | disclosed |
| US-8697734-B2 | Method for controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-04-15 | — | — | US | disclosed |
| US-8637552-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-01-28 | — | — | US | disclosed |
| US-20130028879-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | disclosed |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | disclosed |
| US-20100160307-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-24 | — | — | US | disclosed |
| US-20100152194-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-17 | — | — | US | disclosed |
| US-20080275061-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | FMC CORPORATION | 2008-11-06 | — | — | US | disclosed |
| US-7338978-B2 | Insecticidal anthranilamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-04 | — | — | US | disclosed |
| EP-1427285-B1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | DU PONT (US) | 2007-08-22 | — | — | EP | disclosed |
| EP-1265850-B1 | INSECTICIDAL ANTHRANILAMIDES | DU PONT (US) | 2007-01-03 | — | — | EP | disclosed |
| EP-1700845-A1 | Insecticidal anthranilamides | E.I.Du pont de nemours and company (US) | 2006-09-13 | — | — | EP | disclosed |
| US-20060079561-A1 | Insecticidal anthranilamides | FMC CORPORATION | 2006-04-13 | — | — | US | disclosed |
| US-20050075372-A1 | Method for controlling particular insect pest by applying anthranilamide compounds | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-04-07 | — | — | US | disclosed |
| US-20040209923-A1 | Anthranilamide arthropodicide treatment | FMC CORPORATION | 2004-10-21 | — | — | US | disclosed |
| US-6747047-B2 | ARTHROPODICIDES | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-06-08 | — | — | US | disclosed |
| US-20030229050-A1 | Insecticidal anthranilamides | FMC CORPORATION | 2003-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160307-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | ANTXR2, HRH4, HDAC10 | EPHX2 1941/4885HSD11B1 3218/4885KDM4E 309/4885 |
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | ANTXR2, NIT2, TDO2 | EPHX2 1944/4885HSD11B1 3524/4885KDM4E 415/4885 |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | EPHX2 2997/4885HSD11B1 4745/4885KDM4E 3625/4885 |
| US-20040209923-A1 | Anthranilamide arthropodicide treatment | ANTXR2, ARF5, NPM1 | EPHX2 2927/4885HSD11B1 4631/4885KDM4E 3875/4885 |
| US-20060079561-A1 | Insecticidal anthranilamides | ANTXR2, CYB5R3, NIT2 | EPHX2 795/4885HSD11B1 2374/4885KDM4E 1284/4885 |
| US-20030229050-A1 | Insecticidal anthranilamides | ANTXR2, NIT2, CYB5R3 | EPHX2 913/4885HSD11B1 2601/4885KDM4E 1313/4885 |
| US-20130028879-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | ANTXR2, CYP4X1, PRDX1 | EPHX2 677/4885HSD11B1 2034/4885KDM4E 285/4885 |
| US-20100152194-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | EPHX2 2997/4885HSD11B1 4745/4885KDM4E 3625/4885 |
| US-20080275061-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | ANTXR2, HRH4, HDAC10 | EPHX2 1941/4885HSD11B1 3218/4885KDM4E 309/4885 |
| US-20050075372-A1 | Method for controlling particular insect pest by applying anthranilamide compounds | ANTXR2, HRH4, HDAC10 | EPHX2 2092/4885HSD11B1 3276/4885KDM4E 276/4885 |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | EPHX2 2997/4885HSD11B1 4745/4885KDM4E 3625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.